Department of Medicine, Koc University School of Medicine, Istanbul, Turkey.
Department of Medicine, Division of Nephrology, Suleyman Demirel University School of Medicine, Isparta, Turkey.
Hypertens Res. 2019 Feb;42(2):123-140. doi: 10.1038/s41440-018-0144-z. Epub 2018 Nov 30.
The health and proper functioning of the cardiovascular and renal systems largely depend on crosstalk in the gut-kidney-heart/vessel triangle. Recent evidence suggests that the gut microbiota has an integral function in this crosstalk. Mounting evidence indicates that the development of chronic kidney and cardiovascular diseases follows chronic inflammatory processes that are affected by the gut microbiota via various immune, metabolic, endocrine, and neurologic pathways. Additionally, deterioration of the function of the cardiovascular and renal systems has been reported to disrupt the original gut microbiota composition, further contributing to the advancement of chronic cardiovascular and renal diseases. Considering the interaction between the gut microbiota and the renal and cardiovascular systems, we can infer that interventions for the gut microbiota through diet and possibly some medications can prevent/stop the vicious cycle between the gut microbiota and the cardiovascular/renal systems, leading to a decrease in chronic cardiovascular and renal diseases.
心血管和肾脏系统的健康和正常功能在很大程度上取决于肠道-肾脏-心脏/血管三角区的相互作用。最近的证据表明,肠道微生物群在这种相互作用中具有不可或缺的功能。越来越多的证据表明,慢性肾脏和心血管疾病的发展遵循慢性炎症过程,这些过程受肠道微生物群通过各种免疫、代谢、内分泌和神经途径的影响。此外,心血管和肾脏系统功能的恶化据报道会破坏原始肠道微生物群组成,进一步促进慢性心血管和肾脏疾病的进展。考虑到肠道微生物群与肾脏和心血管系统之间的相互作用,我们可以推断,通过饮食和可能的一些药物对肠道微生物群进行干预,可以防止/阻止肠道微生物群和心血管/肾脏系统之间的恶性循环,从而降低慢性心血管和肾脏疾病的发病率。